このエントリーをはてなブックマークに追加
ID 38137
本文ファイル
著者
Sakano, Takashi
Hamasaki, Takashi
Shimizu, Hiroshi
Harada, Yoshiaki
Ueda, Kazuhiro
キーワード
Intravenous immunoglobulin
Myasthenia gravis
NDC
医学
抄録(英)
A 7-year-old girl with ocular myasthenia gravis (MG) refractory to prednisolone and anticholinesterase compounds was treated with high-dose intravenous immunoglobulin (IVIg). Ocular symptoms disappeared rapidly by the administration of IVIg 300 mg/kg/day for five consecutive days. Booster infusions of IVIg at an interval of 2 weeks appeared to be effective in maintaining a remission at least as an adjunct to prednisolone. The levels of acetylcholine receptor (AchR) antibodies were not correlated with clinical improvement or aggravation. Thus, high-dose IVIg may be useful in refractory cases of MG, allowing a reduction in doses of immunosuppressive drugs.
掲載誌名
Hiroshima Journal of Medical Sciences
37巻
1号
開始ページ
7
終了ページ
9
出版年月日
1988-03
出版者
Hiroshima University Medical Press
ISSN
0018-2052
NCID
PubMedID
言語
英語
NII資源タイプ
紀要論文
広大資料タイプ
学内刊行物(紀要等)
DCMIタイプ
text
フォーマット
application/pdf
著者版フラグ
publisher
部局名
医歯薬学総合研究科
他の一覧